NCT07071714View on ClinicalTrials.gov

A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 22, 2025

Primary Completion Date

October 31, 2031

Study Completion Date

October 31, 2031

Conditions
Colorectal Cancer
Interventions
DRUG

SHR-8068 Injection

SHR-8068 injection.

DRUG

Adebrelimab Injection

Adebrelimab injection.

DRUG

Bevacizumab Injection

Bevacizumab injection.

Trial Locations (1)

510655

RECRUITING

The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

INDUSTRY